ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $623.08 million. The enterprise value is $264.54 million.

Market Cap	623.08M
Enterprise Value	264.54M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 229.92 million shares outstanding. The number of shares has increased by 0.28% in one year.

Shares Outstanding	229.92M
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.92%
Owned by Insiders (%)	22.98%
Owned by Institutions (%)	60.70%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.94

Current Ratio	14.94
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,455.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-7.70%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$217,595
Employee Count	163
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid $6.00 million in taxes.

Income Tax	6.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.33% in the last 52 weeks. The beta is 1.29, so ProKidney's price volatility has been higher than the market average.

Beta (1Y)	1.29
52-Week Price Change	-76.33%
50-Day Moving Average	1.67
200-Day Moving Average	4.03
Relative Strength Index (RSI)	64.50
Average Volume (30 Days)	708,438

Short Selling Information

The latest short interest is 13.98 million, so 6.08% of the outstanding shares have been sold short.

Short Interest	13.98M
Short Previous Month	14.61M
Short % of Shares Out	6.08%
Short % of Float	n/a
Short Ratio (days to cover)	24.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-151.52M
Pretax Income	-29.47M
Net Income	-35.47M
EBITDA	-25.61M
EBIT	-29.46M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

The company has $362.95 million in cash and $4.41 million in debt, giving a net cash position of $358.54 million or $1.56 per share.

Cash & Cash Equivalents	362.95M
Total Debt	4.41M
Net Cash	358.54M
Net Cash Per Share	$1.56
Equity / Book Value	-1.10B
Book Value Per Share	-4.80
Working Capital	349.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$90.07 million and capital expenditures -$34.20 million, giving a free cash flow of -$124.27 million.

Operating Cash Flow	-90.07M
Capital Expenditures	-34.20M
Free Cash Flow	-124.27M
FCF Per Share	-$2.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.28%
Shareholder Yield	-0.28%
Earnings Yield	-5.69%
FCF Yield	-19.94%

Dividend Details

Analyst Forecast

The average price target for ProKidney is $7.00, which is 158.30% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	158.30%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	Jul 12, 2022
Split Type	n/a
Split Ratio	1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a